| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Sales - EUR | - | - | - | - | - | 0 | 0 | 5.069 | 11.523 | 4.393 |
| Total Income - EUR | - | - | - | - | - | 0 | 0 | 5.069 | 11.523 | 27.248 |
| Total Expenses - EUR | - | - | - | - | - | 5.940 | 194 | 6.638 | 9.619 | 19.711 |
| Gross Profit/Loss - EUR | - | - | - | - | - | -5.940 | -194 | -1.568 | 1.904 | 7.537 |
| Net Profit/Loss - EUR | - | - | - | - | - | -5.940 | -194 | -1.720 | 1.600 | 6.331 |
| Employees | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
Check the financial reports for the company - Novophysio S.r.l.
| 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Fixed Assets | - | - | - | - | - | 961 | 821 | 46.744 | 40.363 | 61.185 |
| Current Assets | - | - | - | - | - | 1.576 | 1.465 | 3.459 | 2.637 | 860 |
| Inventories | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Receivables | - | - | - | - | - | 0 | 0 | 0 | 0 | 519 |
| Cash | - | - | - | - | - | 1.576 | 1.465 | 3.459 | 2.637 | 341 |
| Shareholders Funds | - | - | - | - | - | -5.733 | -5.800 | -7.538 | -5.956 | 408 |
| Social Capital | - | - | - | - | - | 207 | 202 | 203 | 202 | 201 |
| Debts | - | - | - | - | - | 8.269 | 8.086 | 57.741 | 48.957 | 61.657 |
| Income in Advance | - | - | - | - | - | 0 | 0 | 0 | 0 | 0 |
| Exchange rate - RON | 4.9743 | 4.9465 | 4.9315 | 4.9468 | 4.8371 | 4.7454 | 4.6535 | 4.5681 | 4.4908 | 4.445 |
| Main CAEN | "8690 - 8690" | |||||||||
| CAEN Financial Year |
8690
|
|||||||||
Comments - Novophysio S.r.l.